Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Videos

The professor of neurology at the University of Texas Health Science Center San Antonio discussed some of the challenges with therapeutic development for OPMD, as well as advances and barriers to gene therapy approaches. [WATCH TIME: 4 minutes]

Translating Oculopharyngeal Muscular Dystrophy Research Into Clinical Application: Matthew Wicklund, MD

The clinical associate professor of neurology and neurosurgery at NYU Langone Health emphasized the importance of rapid, targeted blood pressure reduction and bundled care to improve outcomes in patients with intracerebral hemorrhage. [WATCH TIME: 4 minutes]

The Key Role of Early and Balanced Blood Pressure Control in ICH Management: Kara R. Melmed, MD

Articles

Relative to previously approved therapies like rimegepant, ubrogepant, and zavegepant, AXS-07 resulted in better 2-hour pain relief, sustained pain relief, and reduced use of rescue medications.

AXS-07 Outperforms Other CGRP-Targeting Gepants in Meta-Analysis

The Melissa and Paul Anderson President’s Distinguished Professor of Neurology, Perelman School of Medicine, University of Pennsylvania discussed evolving insights into the cellular immunology of multiple sclerosis. [WATCH TIME: 4 minutes]

Understanding the Cellular Drivers of MS Progression and Treatment Response: Amit Bar-Or, MD, FRCPC, FAAN, FANA

Clinical associate professor of neurology and neurosurgery at NYU Langone Health. 

Senior vice president of research at The ALS Association. 

The senior vice president of research at The ALS Association talked about a multidisciplinary session presented at the 2025 MDA Conference that highlighted diverse strategies for neural repair, from pharmacological targets to noninvasive brain stimulation. [WATCH TIME: 6 minutes]

Exploring Multimodal Approaches to Neural Regeneration: Kuldip Dave, PhD

Marco Meglio, Assistant Managing Editor for 

, has been with the team since October 2019. Follow him on Twitter 

In this final episode, neurologists discuss the role of advanced imaging, like OCT, in diagnosing and managing MS, emphasizing the need for further research to optimize its clinical application. [WATCH TIME: 2 minutes]

Bridging Neurology and Ophthalmology in Multiple Sclerosis Research

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AAN 2025

AD/PD 2025

MDA 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

1rem

View

Introduction to CMSC Best Practices in Multiple Sclerosis Therapies Roundtable 

Best Practices in Multiple Sclerosis

Best Practices in Multiple Sclerosis: Discussion

Best Practices for Therapeutic Selection in Relapsing Multiple Sclerosis

Therapeutic Selection in Relapsing Multiple Sclerosis: Key Concepts

Best Practices for Therapeutic Selection in Relapsing Multiple Sclerosis: Discussion

Therapeutic Selection for Progressive Multiple Sclerosis

Considerations in Therapeutic Selection for Progressive Multiple Sclerosis

Therapeutic Selection for Progressive Multiple Sclerosis: Discussion

Patients With Features of Aggressive Multiple Sclerosis or Poor Prognosis

Safety Concerns and Discussion: Highly Active Multiple Sclerosis

Therapeutic Goals of Treating Multiple Sclerosis 

Indicators of Suboptimal Therapies 

Therapeutic Selection in Pediatric-Onset Multiple Sclerosis

Best Practices for Treating Pediatric Patients

Therapeutic Selection in Pediatric-Onset Multiple Sclerosis: Discussion 

Best Practices for DMTs for Pregnant Patients With Multiple Sclerosis  

Multiple Sclerosis Drugs During Pregnancy 

Relapse Therapy and Postpartum Care for Pregnant Patients With Multiple Sclerosis 

Monitoring Efficacy of Treatment in Patients With Multiple Sclerosis 

Discussion: Monitoring Efficacy of Treatment in Patients With Multiple Sclerosis

Issues in Therapeutic Selection for Multiple Sclerosis 

Considerations When Selecting an Optimal DMT for Multiple Sclerosis Treatment 

Best Practices in Multiple Sclerosis Therapies: Future Perspectives

Expert Insights on the Best Practices of Multiple Sclerosis: Summary

Closing Thoughts: CMSC Best Practices in Multiple Sclerosis Therapies Roundtable

An expert-led panel discuss the best practices and different treatment considerations in multiple sclerosis.

Clinical

EMD-22-NRD0193 - /clinical/multiple-sclerosis

CMSC Best Practices in Multiple Sclerosis Therapies Roundtable